Literature DB >> 984805

Susceptibility of respiratory tract anaerobes to orally administered penicillins and cephalosporins.

D F Busch, L A Kureshi, V L Sutter, S M Finegold.   

Abstract

Anaerobic bacteria recovered from airway-related infections were tested by agar dilution against selected penicillins and cephalosporins available for oral administration. Against 136 isolates, penicillins G and V showed comparable activity, particularly when pharmacological differences were considered. Although many isolates were exquisitely susceptible to the penicillins, only 55% of the Bacteroides species and 72% of all isolates were inhibited at 0.5 mug of penicillin G per ml. Results for penicillin V at 1 mug/ml were similar (59 and 73%). The two cephalosporins were more active at achievable levels, inhibiting 94 to 95% of Bacteroides and 95 to 96% of all isolates at 8 mug/ml. These levels represent approximately 50% of the reported peak serum levels after oral administration of 625 mg of the penicillins and 500 mg of the cephalosporins. Dicloxacillin and nafcillin were tested against 50 isolates. The two were comparably active on a weight basis; dicloxacillin was more active when pharmacological differences were considered, but did not match the other penicillins or the cephalosporins.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 984805      PMCID: PMC429819          DOI: 10.1128/AAC.10.4.713

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  DICLOXACILLIN. IN VITRO AND PHARMACOLOGIC COMPARISONS WITH OXACILLIN AND CLOXACILLIN.

Authors:  C F GRAVENKEMPER; J V BENNETT; J L BRODIE; W M KIRBY
Journal:  Arch Intern Med       Date:  1965-09

2.  Antimicrobial activity and human pharmacology of amoxicillin.

Authors:  H C Neu
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

3.  Anaerobic infections of the lung and pleural space.

Authors:  J G Bartlett; S M Finegold
Journal:  Am Rev Respir Dis       Date:  1974-07

4.  Bacteriology of aspiration pneumonia. A prospective study of community- and hospital-acquired cases.

Authors:  B Lorber; R M Swenson
Journal:  Ann Intern Med       Date:  1974-09       Impact factor: 25.391

5.  Infections due to anaerobes.

Authors:  S M Finegold
Journal:  Med Times       Date:  1968-02

6.  Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates.

Authors:  J L Staneck; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

7.  Methicillin-resistant staphylococci 1965-75.

Authors:  F H Kayser
Journal:  Lancet       Date:  1975-10-04       Impact factor: 79.321

8.  Cephradine absorption and excretion in fasting and nonfasting volunteers.

Authors:  C Harvengt; P De Schepper; F Lamy; J Hansen
Journal:  J Clin Pharmacol New Drugs       Date:  1973-01

9.  Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs.

Authors:  V L Sutter; S M Finegold
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

10.  Susceptibility of anaerobic bacteria to 23 antimicrobial agents.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

View more
  11 in total

Review 1.  Antianaerobic antimicrobials: spectrum and susceptibility testing.

Authors:  Itzhak Brook; Hannah M Wexler; Ellie J C Goldstein
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

2.  Fusobacterial infections in children.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

3.  Activity of trospectomycin against Bacteroides fragilis and other Bacteroides species.

Authors:  N V Jacobus; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

4.  Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.

Authors:  P C Appelbaum; S K Spangler; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

5.  Susceptibility of Gardnerella vaginalis to cephradine.

Authors:  E J Goldstein; Y Y Kwok; V L Sutter
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

6.  Bacteriology of dental abscesses of endodontic origin.

Authors:  B L Williams; G F McCann; F D Schoenknecht
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

Review 7.  Antimicrobial drugs used in the management of anaerobic infections in children.

Authors:  I Brook
Journal:  Drugs       Date:  1983-12       Impact factor: 9.546

8.  Comparative antibacterial activity of an arylglycyl oral cephalosporin, LY164846.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

9.  beta-Lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents.

Authors:  M R Jacobs; S K Spangler; P C Appelbaum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

Review 10.  Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome.

Authors:  Terry Riordan
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.